This inventor holds 3 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 2004-2008.
Company Filing History:
Years Active: 2004-2008
Title: Koji Hanasaki: Innovator in Pharmaceutical Chemistry
Introduction
Koji Hanasaki is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on 2-imino-1,3-thiazine derivatives. With a total of 3 patents to his name, Hanasaki continues to push the boundaries of scientific research and development.
Latest Patents
Hanasaki's latest patents focus on 2-imino-1,3-thiazine derivatives. These inventions specifically relate to compounds that exhibit selective antagonistic or agonistic activity to cannabinoid type 2 receptors. The pharmaceutical applications of these derivatives hold promise for various therapeutic uses, showcasing Hanasaki's commitment to advancing medical science.
Career Highlights
Throughout his career, Koji Hanasaki has been associated with Shionogi Company Limited, a leading pharmaceutical company. His work has not only contributed to the company's research initiatives but has also positioned him as a key figure in the development of new therapeutic agents.
Collaborations
Hanasaki has collaborated with notable colleagues, including Takami Murashi and Hiroyuki Kai. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new pharmaceutical solutions.
Conclusion
Koji Hanasaki's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for future advancements in medical treatments.